T1 Glottic Cancer RT — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

EasyHead & Neck CancerT1 Glottic Cancer RTSCE Medical Oncology

A 62-year-old man with early-stage glottic (T1a N0) laryngeal SCC is discussed at the H&N MDT. What is the preferred curative treatment that preserves voice function?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Radical radiotherapy (55-66 Gy)

Early-stage glottic cancer (T1-T2, N0) is one of the most curable cancers with RT alone (5-year local control >90% for T1, ~70-80% for T2). Radiotherapy preserves the larynx and voice quality better than surgical options in most cases. Transoral laser microsurgery (TLM) provides an alternative curative approach with excellent outcomes and is increasingly used for early T1-T2 disease. The choice between RT and TLM depends on tumour location, patient preference and local expertise. Cisplatin chemoRT is NOT needed for T1 glottic cancer.

Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cancer